2026-01-21 - Analysis Report
**Company Overview**
Planet Labs is a satellite technology company that provides data and analytics services.

**Return Rate Comparison**
### Review Stock: Planet Labs
- Cumulative return: **480.47%** vs S&P 500 (VOO) cumulative return: **38.17%**
- Divergence: **454.60%** (max: 454.60, min: -67.40, current: 454.60, relative divergence: **100.00%**)

### Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|--------|
| 2022-2024  | 8.0% | 45.2% | -12.0% | 1.8 | 1.3B   |
| 2023-2025  | 334.0% | 51.0% | 272.0% | 2.2 | 6.5B   |

**Moving Average Analysis**
- Close: **$28.00**
- Last-market: {'price': 28.0, 'previousClose': 28.78, 'change': -2.71}
- 5-day SMA: **$27.42**
- 20-day SMA: **$22.67**
- 60-day SMA: **$16.34**

**RSI, PPO, Delta_Previous_Relative_Divergence, Expected_Return Analysis**
- Market Risk Indicator (MRI): **0.80**
- RSI: **88.46**
- PPO: **1.25**
- Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.80)
Recent (20 days) relative divergence change: **0.00** (0): flat
7-day Rank change: **12** (+): rank up
7-day Dynamic Expected Return change: **0.10** (+): improving
Expected Return (%): **-5.80%** (Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.)

**News Analysis**
There have been recent significant events affecting the stock price:
- 66% increase in the stock price in the last month.
- The company issued earnout shares after price milestones.
- The stock price has fluctuated due to market movements (e.g., +9% today).

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): **1.70** (~Buy)
- Opinions: **9**
- Target Price (avg/high/low): **24.16** / **30.00** / **16.40**

**Earnings Analysis**
### Quarterly Earnings Data

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-28 | 0.82 | 2.21 B$ |
| 2025-07-30 | 0.61 | 2.18 B$ |
| 2025-04-29 | 0.64 | 2.14 B$ |
| 2025-02-14 | 1.38 | 2.20 B$ |
| 2024-10-25 | 1.08 | 2.04 B$ |

**Revenue and Profitability Analysis**
### Quarterly Data

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-10-31 | $0.08B | 57.33% |
| 2025-07-31 | $0.07B | 57.60% |
| 2025-04-30 | $0.07B | 55.24% |
| 2025-01-31 | $0.06B | 62.08% |
| 2024-10-31 | $0.06B | 61.24% |

**Capital and Profitability Analysis**
### Quarterly Data

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-10-31 | $0.35B | -16.93% |
| 2025-07-31 | $0.44B | -5.19% |
| 2025-04-30 | $0.44B | -2.84% |
| 2025-01-31 | $0.44B | -7.97% |
| 2024-10-31 | $0.46B | -4.32% |

**Comprehensive Analysis**
Based on the provided data, the stock price has experienced significant fluctuations, with a high cumulative return of **480.47%** compared to the S&P 500's cumulative return of **38.17%**. The company's market risk indicator (MRI) is at **0.80**, indicating a medium risk level. Analysts recommend buying the stock, with a mean rating of **1.70** and a target price of **24.16**. The recent news and events affecting the stock price suggest a positive outlook for the company's growth and profitability. However, the stock's expected return is -5.80%, indicating a high risk of potential losses.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.